Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | beta-site APP-cleaving enzyme 1 | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target/s | Ortholog Group |
---|---|---|---|
Schistosoma japonicum | ko:K07747 beta-site APP-cleaving enzyme 2 (memapsin 1) [EC3.4.23.45], putative | Get druggable targets OG5_135830 | All targets in OG5_135830 |
Schistosoma mansoni | memapsin-2 (A01 family) | Get druggable targets OG5_135830 | All targets in OG5_135830 |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Plasmodium falciparum | plasmepsin VII | beta-site APP-cleaving enzyme 1 | 401 aa | 352 aa | 21.3 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Mycobacterium ulcerans | L-lysine aminotransferase | 0.0263 | 0.1244 | 0.1244 |
Trypanosoma brucei | metallo-peptidase, Clan MA(E) Family M1 | 0.0038 | 0 | 0.5 |
Echinococcus granulosus | ornithine aminotransferase | 0.0263 | 0.1244 | 1 |
Echinococcus multilocularis | ornithine aminotransferase | 0.0263 | 0.1244 | 1 |
Toxoplasma gondii | ornithine aminotransferase, mitochondrial precursor, putative | 0.0263 | 0.1244 | 0.5 |
Leishmania major | aminopeptidase-like protein,metallo-peptidase, Clan MA(E), Family M1 | 0.0038 | 0 | 0.5 |
Brugia malayi | 4-aminobutyrate aminotransferase, mitochondrial precursor | 0.0263 | 0.1244 | 0.1331 |
Trypanosoma brucei | Aminopeptidase M1, putative | 0.0038 | 0 | 0.5 |
Loa Loa (eye worm) | pax transcription factor protein 2 | 0.1735 | 0.9351 | 1 |
Echinococcus multilocularis | Aminotransferase class III | 0.0263 | 0.1244 | 1 |
Mycobacterium ulcerans | adenosylmethionine-8-amino-7-oxononanoate aminotransferase | 0.1853 | 1 | 1 |
Leishmania major | aminopeptidase, putative,metallo-peptidase, Clan MA(E), Family M1 | 0.0038 | 0 | 0.5 |
Mycobacterium ulcerans | glutamate-1-semialdehyde aminotransferase | 0.0263 | 0.1244 | 0.1244 |
Brugia malayi | Pax transcription factor protein 2 | 0.1735 | 0.9351 | 1 |
Mycobacterium ulcerans | 4-aminobutyrate aminotransferase | 0.0263 | 0.1244 | 0.1244 |
Trypanosoma cruzi | Aminopeptidase M1, putative | 0.0038 | 0 | 0.5 |
Entamoeba histolytica | aminopeptidase, putative | 0.0038 | 0 | 0.5 |
Trichomonas vaginalis | acetylornithine aminotransferase, putative | 0.1853 | 1 | 1 |
Wolbachia endosymbiont of Brugia malayi | acetylornithine transaminase protein | 0.0263 | 0.1244 | 0.5 |
Mycobacterium ulcerans | 4-aminobutyrate aminotransferase | 0.0263 | 0.1244 | 0.1244 |
Trypanosoma cruzi | metallo-peptidase, clan MA(E), family M1, putative | 0.0038 | 0 | 0.5 |
Onchocerca volvulus | 0.1735 | 0.9351 | 1 | |
Trypanosoma cruzi | aminopeptidase, putative | 0.0038 | 0 | 0.5 |
Plasmodium falciparum | ornithine aminotransferase | 0.0263 | 0.1244 | 0.5 |
Mycobacterium ulcerans | hypothetical protein | 0.1853 | 1 | 1 |
Mycobacterium tuberculosis | Probable aminotransferase | 0.1853 | 1 | 1 |
Plasmodium vivax | ornithine aminotransferase, putative | 0.0263 | 0.1244 | 0.5 |
Trypanosoma brucei | Aminopeptidase M1, putative | 0.0038 | 0 | 0.5 |
Schistosoma mansoni | memapsin-2 (A01 family) | 0.0521 | 0.2663 | 1 |
Mycobacterium ulcerans | acetylornithine aminotransferase | 0.0263 | 0.1244 | 0.1244 |
Echinococcus granulosus | Aminotransferase class III | 0.0263 | 0.1244 | 1 |
Schistosoma mansoni | ornithine--oxo-acid transaminase | 0.0263 | 0.1244 | 0.4673 |
Mycobacterium ulcerans | ornithine aminotransferase RocD1 and RocD2 | 0.0263 | 0.1244 | 0.1244 |
Mycobacterium tuberculosis | Adenosylmethionine-8-amino-7-oxononanoate aminotransferase BioA | 0.1853 | 1 | 1 |
Echinococcus multilocularis | ornithine aminotransferase | 0.0263 | 0.1244 | 1 |
Chlamydia trachomatis | glutamate-1-semialdehyde-2,1-aminomutase | 0.0263 | 0.1244 | 0.5 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.